Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)

NCT00127114 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00127114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00127114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Lead sponsor
Johns Hopkins University
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2005
Completion date
July 26, 2007
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia